Mochida Pharmaceutical Co Ltd (4534) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Mochida Pharmaceutical Co Ltd (Mochida) is a pharmaceutical company that develops, manufactures and markets drugs and diagnostic regents. The companys drugs are used for the treatment of arteriosclerosis obliterans, hyperlipidemia, hypertension, angina pectoris, endometriosis, mycosis, thrombosis, acute circulatory failure, acute pancreatitis, acute myocardial infarction, depression and depressive symptoms, chronic pain, diabetes, neutropenia and others. Its products under development are intended for the treatment of ulcerative colitis, rheumatoid arthritis, adenomyosis, osteoporosis, articular cartilage lesion, chronic constipation and others. The company also offers contract manufacturing of pharmaceuticals. Mochida is headquartered in Tokyo, Japan.

Mochida Pharmaceutical Co Ltd (4534) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
EA Pharma and Mochida Pharma Enter into Joint Development Agreement 10
Mochida Pharma Enters into Distribution Agreement with United Therapeutics 11
Mochida Pharma Enters into Agreement with Fuji Yakuhin 12
Gene Techno Science Enters into Co-Development Agreement with Mochida Pharma 13
Ajinomoto Pharma and Mochida Pharma Enter into Co-Development Agreement 14
Mochida Pharma Enters Into Agreement With Hospira Japan To Distribute And Promote Oncology Products 15
Licensing Agreements 16
Amarin Enters into Licensing Agreement with Mochida Pharma 16
Meiji Seika Pharma Receives Rights of Epadail S from Mochida Pharma 17
LG Life Sciences Enters into Licensing Agreement with Mochida Pharma 18
LG Life Sciences Enters Into License Agreement With Mochida For Biosimilar Antibody Drugs 19
Mochida Pharmaceutical Co Ltd - Key Competitors 20
Mochida Pharmaceutical Co Ltd - Key Employees 21
Mochida Pharmaceutical Co Ltd - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables


Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mochida Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
EA Pharma and Mochida Pharma Enter into Joint Development Agreement 10
Mochida Pharma Enters into Distribution Agreement with United Therapeutics 11
Mochida Pharma Enters into Agreement with Fuji Yakuhin 12
Gene Techno Science Enters into Co-Development Agreement with Mochida Pharma 13
Ajinomoto Pharma and Mochida Pharma Enter into Co-Development Agreement 14
Mochida Pharma Enters Into Agreement With Hospira Japan To Distribute And Promote Oncology Products 15
Amarin Enters into Licensing Agreement with Mochida Pharma 16
Meiji Seika Pharma Receives Rights of Epadail S from Mochida Pharma 17
LG Life Sciences Enters into Licensing Agreement with Mochida Pharma 18
LG Life Sciences Enters Into License Agreement With Mochida For Biosimilar Antibody Drugs 19
Mochida Pharmaceutical Co Ltd, Key Competitors 20
Mochida Pharmaceutical Co Ltd, Key Employees 21
Mochida Pharmaceutical Co Ltd, Other Locations 22
Mochida Pharmaceutical Co Ltd, Subsidiaries 22

List Of Figures


Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mochida Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Mochida Pharmaceutical Co Ltd (4534) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Mochida Pharmaceutical Co Ltd (Mochida) is a pharmaceutical company that develops, manufactures and markets drugs and diagnostic regents. The companys drugs are used for the treatment of arteriosclerosis obliterans, hyperlipidemia,

USD 250 View Report

Mochida Pharmaceutical Co Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Mochida Pharmaceutical Co Ltd Company Profile is a detailed strategic and analytical report on Mochida Pharmaceutical Co Ltd. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Xiangxue Pharmaceutical Co Ltd (300147) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The companys products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal

USD 250 View Report

Hunan Fangsheng Pharmaceutical Co Ltd (603998) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hunan Fangsheng Pharmaceutical Co Ltd (Fangsheng Pharma) is a research-based comprehensive pharmaceutical enterprise offers research, development, manufacturing and sales of pharmaceuticals. The enterprise products include tablets, capsules, granules, oral suspension,

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available